Cart
sales@molnova.com
Serplulimab
CAS No. 2231029-82-4
Serplulimab( —— )
Catalog No. M36682 CAS No. 2231029-82-4
Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 353 | In Stock |
|
| 10MG | 567 | In Stock |
|
| 25MG | 888 | In Stock |
|
| 50MG | 1172 | In Stock |
|
| 100MG | 1572 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSerplulimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionSerplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.
-
DescriptionSerplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2231029-82-4
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee A. Serplulimab: First Approval. Drugs. 2022 Jul;82(10):1137-1141.?
molnova catalog
related products
-
Tolmetin
Tolmetin is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of tolmetin is as a Cyclooxygenase Inhibitor.
-
Naproxen sodium
Naproxen is a?COX?inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.
-
Canolol
Canolol is an antioxidant phenolic compound that has potential use as a COX-2 inhibitor.
